Industry Verticals »

All Categories

Insights »

About TMR »

Testosterone Replacement Therapy Market

Testosterone Replacement Therapy Market (Product - Creams/Gels, Patches, Injections, Gums/Buccal Adhesives, Implants; Active Ingredient - Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global testosterone replacement therapy market for the historical period 2017–2018 and forecast period 2019–2027, increasing incidence of testosterone deficiency, growing awareness among people regarding testosterone replacement therapy, and a significant pipeline of medications, are projected to drive the global market for testosterone replacement therapy during the forecast period
  • According to the report, the global testosterone replacement therapy market was valued at US$ 1,613.7 Mn in 2018 and is anticipated to expand at a CAGR of 4.4% from 2019 to 2027

global testosterone replacement therapy market

Rising incidence of testosterone deficiency: Key Drivers

  • Testosterone deficiency, also known as hypogonadism, is characterized by diminished functioning of the male gonads that reduces testosterone secretion. This occurs mainly due to hypothalamic-pituitary axis dysfunction and/or testicular failure.
  • Testosterone deficiency is one of the common health problems among men aged between 40 years and 79 years. The incidence of low testosterone levels in men aged over 60 years is estimated to be around 20% of the male population, and in the population aged over 70 years, around 30%. The global prevalence of testosterone deficiency ranges from over 10% to 40% of the population.
  • However, only around 9% of patients with testosterone deficiency are being treated in the U.S. This is due to factors such as the perceived risk of prostate cancer associated with current treatment therapy and lack of screening/tests for low testosterone. Therefore, an increase in the incidence rate of testosterone deficiency is expected to drive the testosterone replacement therapy products market in the near future.

Rise in Geriatric Population with High Risk of Testosterone Deficiency Boost Market Growth

  • The world population is aging rapidly, especially in some of the developed economies such as the U.S., most of Western Europe, and Japan. Developed economies present high rates of aging. This is attributed to improved healthcare infrastructure, policies, and advancement in healthcare facilities in these countries. Moreover, access to various diagnostic and treatment services has improved in the recent past, especially in developed economies. This in turn has increased the life expectancy of the population.
  • According to World Health Organization (WHO) estimates, the global geriatric population is likely to reach around 2 billion (22% of the global population) by 2050 as compared to 524 million in 2010. The geriatric population would rise at the fastest rate in developed countries such as the U.K., Germany, the U.S., and Japan. However, Brazil, China, Thailand, and South Korea are also expected to have a large geriatric population base in the shortest span of time in the near future.
  • Testosterone levels decrease naturally as age increases beyond 30 years. However, in some cases, the significant decreases can lead to health problems. The world population is rapidly aging. Therefore, with the increasing population of aged individuals, the testosterone-deficient men population would also grow, which in turn would increase the demand for testosterone replacement therapy in the global market. Hence, an increase in the geriatric population is expected to fuel the growth of the testosterone replacement therapy market globally

Patent Expiry of Key Drugs and Entry of Generics Hamper Market

  • The testosterone replacement therapy market is expected to experience a patent cliff during the forecast period. The expiration of key drug patents would affect the revenues of large pharmaceutical companies from TRT products. In addition, the generic versions of these drugs would further reduce the global market revenues as these would be priced much lower than their counterparts (branded drugs) that dominated the global market earlier.
  • This factor is expected to have a profound effect on the overall testosterone replacement therapy products market, causing a drastic dip in market revenues. Moreover, approved ANDAs for most of these molecules will lead to intense generic competition.
  • Therefore, patent expirations are likely to significantly impact and restrain the testosterone replacement therapy industry in the near future.

Global Testosterone replacement therapy Market: Competitive Landscape

  • This report profiles major players in the global testosterone replacement therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market for testosterone replacement therapy is highly consolidated, with the top five players accounting for over 60% of the market.
  • Leading players operating in the global testosterone replacement therapy business are
    • AbbVie, Inc.
    • Allergan plc
    • Bayer AG
    • Endo Pharmaceuticals, Inc.
    • Eli Lilly Company
    • Kyowa Kirin International plc
    • Mylan N.V.
    • Novartis AG
    • Pfizer, Inc.
    • Clarus Therapeutics,
    • Ferring Holding SA,

Global Testosterone replacement therapy Industry: Key Developments

Key players in the global testosterone replacement therapy market are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few product launches in the global market is:

  • In April 2019, the U.S. FDA approved a generic version of testosterone gel 1.62% as replacement therapy for men with hypogonadism.
  • In March 2019, the U.S. FDA approved Jatenzo, an oral testosterone capsule, manufactured by Clarus Therapeutics for the treatment of certain forms of hypogonadism.

The report on the global market for testosterone replacement therapy discussed individual strategies, followed by company profiles of manufacturers of testosterone replacement therapy. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global testosterone replacement therapy market.

Frequently Asked Questions

How big was the global testosterone replacement therapy market in 2018?

The global TRT market was valued at US$ 1,613.7 Mn in 2018

What is the total market worth of testosterone replacement therapy?

The testosterone replacement therapy industry is anticipated to expand at a CAGR of 4.4% from 2019 to 2027

What is the anticipated CAGR of the global market for testosterone replacement therapy in the forecast period?

The testosterone replacement therapy market is to reach a value of USD 2,296.2 Mn by the end of 2027

What are the key driving factors for the growth of the testosterone replacement therapy business?

Testosterone replacement therapy market is driven by rise in geriatric population with high risk of testosterone deficiency

Who are the key players in the testosterone replacement therapy industry?

Key players in the global market for testosterone replacement therapy include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly Company

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Testosterone Replacement Therapy Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Testosterone Replacement Therapy Market Analysis and Forecast, 2017-2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Pricing Analysis: Testosterone Replacement Therapy Market, by Product, (US$) 2018

        5.2. Pipeline Analysis: Testosterone Replacement Therapy

        5.3. TRT Technology Development Timeline

    6. Global Testosterone Replacement Therapy Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Testosterone Replacement Therapy Market Value Forecast, by Type, 2017-2027

            6.2.1. Creams/Gels

            6.2.2. Patches

            6.2.3. Injections

            6.2.4. Gums/Buccal Adhesives

            6.2.5. Implants

            6.2.6. Oral

        6.3. Global Testosterone Replacement Therapy Market Attractiveness, by Type

    7. Global Testosterone Replacement Therapy Market Analysis and Forecast, by Active Ingredient Type

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Testosterone Replacement Therapy Market Value Forecast, by Active Ingredient Type, 2017-2027

            7.2.1. Testosterone

            7.2.2. Methyl Testosterone

            7.2.3. Testosterone Undecanoate

            7.2.4. Testosterone Enanthate

            7.2.5. Testosterone Cypionate

        7.3. Global Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type

    8. Global Testosterone Replacement Therapy Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Testosterone Replacement Therapy Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. North America Testosterone Replacement Therapy Market Attractiveness, by Region

    9. North America Testosterone Replacement Therapy Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

            9.2.1. Creams/Gels

            9.2.2. Patches

            9.2.3. Injections

            9.2.4. Gums/Buccal Adhesives

            9.2.5. Implants

            9.2.6. Oral

        9.3. North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

            9.3.1. Testosterone

            9.3.2. Methyl Testosterone

            9.3.3. Testosterone Undecanoate

            9.3.4. Testosterone Enanthate

            9.3.5. Testosterone Cypionate

        9.4. North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country, 2017-2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Testosterone Replacement Therapy Market Attractiveness Analysis

            9.5.1. By Product Type

            9.5.2. By Active Ingredient Type

            9.5.3. By Country

    10. Europe Testosterone Replacement Therapy Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Type, 2017-2027

            10.2.1. Creams/Gels

            10.2.2. Patches

            10.2.3. Injections

            10.2.4. Gums/Buccal Adhesives

            10.2.5. Implants

            10.2.6. Oral

        10.3. Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

            10.3.1. Testosterone

            10.3.2. Methyl Testosterone

            10.3.3. Testosterone Undecanoate

            10.3.4. Testosterone Enanthate

            10.3.5. Testosterone Cypionate

        10.4. Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Testosterone Replacement Therapy Market Attractiveness Analysis

            10.5.1. By Product Type

            10.5.2. By Active Ingredient Type

            10.5.3. By Country/Sub-region

    11. Asia Pacific Testosterone Replacement Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

            11.2.1. Creams/Gels

            11.2.2. Patches

            11.2.3. Injections

            11.2.4. Gums/Buccal Adhesives

            11.2.5. Implants

            11.2.6. Oral

        11.3. Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

            11.3.1. Testosterone

            11.3.2. Methyl Testosterone

            11.3.3. Testosterone Undecanoate

            11.3.4. Testosterone Enanthate

            11.3.5. Testosterone Cypionate

        11.4. Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Testosterone Replacement Therapy Market Attractiveness Analysis

            11.5.1. By Type

            11.5.2. By Active Ingredient Type

            11.5.3. By Country/Sub-region

    12. Latin America Testosterone Replacement Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

            12.2.1. Creams/Gels

            12.2.2. Patches

            12.2.3. Injections

            12.2.4. Gums/Buccal Adhesives

            12.2.5. Implants

            12.2.6. Oral

        12.3. Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

            12.3.1. Testosterone

            12.3.2. Methyl Testosterone

            12.3.3. Testosterone Undecanoate

            12.3.4. Testosterone Enanthate

            12.3.5. Testosterone Cypionate

        12.4. Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America Latin America

        12.5. Latin America Testosterone Replacement Therapy Market Attractiveness Analysis

            12.5.1. By Product Type

            12.5.2. By Active Ingredient Type

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Testosterone Replacement Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

            13.2.1. Creams/Gels

            13.2.2. Patches

            13.2.3. Injections

            13.2.4. Gums/Buccal Adhesives

            13.2.5. Implants

            13.2.6. Oral

        13.3. Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

            13.3.1. Testosterone

            13.3.2. Methyl Testosterone

            13.3.3. Testosterone Undecanoate

            13.3.4. Testosterone Enanthate

            13.3.5. Testosterone Cypionate

        13.4. Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Testosterone Replacement Therapy Market Attractiveness Analysis

            13.5.1. By Product Type

            13.5.2. By Active Ingredient Type

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company, 2018

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. AbbVie, Inc.

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Growth Strategies

                14.4.1.3. SWOT Analysis

            14.4.2. Allergan plc

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Growth Strategies

                14.4.2.3. SWOT Analysis

            14.4.3. Bayer AG

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Growth Strategies

                14.4.3.3. SWOT Analysis

            14.4.4. Endo Pharmaceuticals, Inc.

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Growth Strategies

                14.4.4.3. SWOT Analysis

            14.4.5. Eli Lilly and Company

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Growth Strategies

                14.4.5.3. SWOT Analysis

            14.4.6. Kyowa Kirin International plc

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Growth Strategies

                14.4.6.3. SWOT Analysis

            14.4.7. Mylan N.V.

                14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.7.2. Growth Strategies

                14.4.7.3. SWOT Analysis

            14.4.8. Novartis AG

                14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.8.2. Growth Strategies

                14.4.8.3. SWOT Analysis

            14.4.9. Pfizer, Inc.

                14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.9.2. Growth Strategies

                14.4.9.3. SWOT Analysis

            14.4.10. Clarus Therapeutics

                14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.10.2. Growth Strategies

                14.4.10.3. SWOT Analysis

            14.4.11. Ferring Holding SA

                14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.11.2. Growth Strategies

                14.4.11.3. SWOT Analysis

    List of Tables

    Table 1: Global Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

    Table 2: Global Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

    Table 3: Global Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Region, 2017-2027

    Table 4: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 5: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

    Table 6: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

    Table 7: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 8: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

    Table 9: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

    Table 10: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 11: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

    Table 12: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

    Table 13: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 14: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

    Table 15: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

    Table 16: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 17: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2027

    Table 18: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast, by Active Ingredient Type, 2017-2027

    List of Figures

    Figure 1: Global Testosterone Replacement Therapy Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 2: Global Testosterone Replacement Therapy Market Value (US$ Mn) and Forecast, 2019-2027

    Figure 3: Global Testosterone Replacement Therapy Market Value Share (%), by Product Type, 2018

    Figure 4: Global Testosterone Replacement Therapy Market Value Share (%), by Active Ingredient Type, 2018

    Figure 5: Global Testosterone Replacement Therapy Market Value Share (%), by Region, 2018

    Figure 6: Global Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 7: Global Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

    Figure 8: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Creams/Gels, 2017-2027

    Figure 9: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Patches, 2017-2027

    Figure 10: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Injections, 2017-2027

    Figure 11: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gums/Buccal Adhesives, 2017-2027

    Figure 12: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Implants, 2017-2027

    Figure 13: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017-2027

    Figure 14: Global Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

    Figure 15: Global Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

    Figure 16: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone, 2017-2027

    Figure 17: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Methyl Testosterone, 2017-2027

    Figure 18: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone Undecanoate, 2017-2027

    Figure 19: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone Enanthate, 2017-2027

    Figure 20: Global Testosterone Replacement Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Testosterone Cypionate, 2017-2027

    Figure 21: Global Testosterone Replacement Therapy Market Value Share, by Region, 2018 and 2027

    Figure 22: Global Testosterone Replacement Therapy Market Attractiveness, by Region, 2019-2027

    Figure 23: North America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 24: North America Testosterone Replacement Therapy Market Value Share Analysis, by Country, 2018 and 2027

    Figure 25: North America Testosterone Replacement Therapy Market Attractiveness, by Country, 2019-2027

    Figure 26: North America Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 27: North America Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

    Figure 28: North America Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

    Figure 29: North America Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

    Figure 30: Europe Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 31: Europe Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 32: Europe Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

    Figure 33: Europe Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 34: Europe Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

    Figure 35: Europe Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

    Figure 36: Europe Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

    Figure 37: Asia Pacific Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 38: Asia Pacific Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 39: Asia Pacific Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

    Figure 40: Asia Pacific Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 41: Asia Pacific Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

    Figure 42: Asia Pacific Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

    Figure 43: Asia Pacific Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

    Figure 44: Latin America Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 45: Latin America Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 46: Latin America Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

    Figure 47: Latin America Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 48: Latin America Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

    Figure 49: Latin America Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

    Figure 50: Latin America Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

    Figure 51: Middle East & Africa Testosterone Replacement Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 52: Middle East & Africa Testosterone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 53: Middle East & Africa Testosterone Replacement Therapy Market Attractiveness, by Country/Sub-region, 2019-2027

    Figure 54: Middle East & Africa Testosterone Replacement Therapy Market Value Share Analysis, by Product Type, 2018 and 2027

    Figure 55: Middle East & Africa Testosterone Replacement Therapy Market Attractiveness, by Product Type, 2019-2027

    Figure 56: Middle East & Africa Testosterone Replacement Therapy Market Value Share Analysis, by Active Ingredient Type, 2018 and 2027

    Figure 57: Middle East & Africa Testosterone Replacement Therapy Market Attractiveness, by Active Ingredient Type, 2019-2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Testosterone Replacement Therapy Market

Schedule a Call